DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Antipsychotic Drugs Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except Halodol and lithium carbonate, all first generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters.
Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With development of technology and growing competition to gain largest market share, researchers are focusing on first generation antipsychotics to better understand their working mechanism.
Abilify and Seroquel are topmost marketed brands due their high therapeutic efficacy and reduced side effects.
The key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this market. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012.
MARKET BY APPLICATION
- Bipolar Disorder
- Unipolar Depression
MARKET BY BRANDS
First Generation Drugs (Standard / Typical Antipsychotic Agents)
- Thorazine (Chlorpromazine HCl)
- Serentil (Mesoridazine Besylate)
- Mellaril (Thioridazine HCl)
- Haldol (Haloperidol)
- Loxitane (Loxapine Succinate)
- Trilafon (Perphenazine)
- Navane (Thiothixene)
- Sordinol (Clopenthixol)
Second generation Drugs (Atypical Antipsychotic Agents)
- Zyprexa (Olanzapine)
- Geodon (Ziprasidone)
- Seroquel (Quetiapine)
- Risperdal (Risperidone)
- Clozaril (Clozapine)
- Invega (Paliperidone)
- Asendin (Amoxapine)
- Latuda (Lurasidone)
Third generation Drugs
- Abilify (Aripiprazole)
For more information about this report visit http://www.researchandmarkets.com/research/bcr2c6/world